bioRN News
BASF creates chemistry for a sustainable future, combining economic success with environmental protection and social responsibility. With about 112,000 employees worldwide, BASF supports customers across nearly all sectors. In pharmaceuticals, BASF delivers high-quality excipients and active ingredients, supporting effective, reliable formulations. With deep expertise in drug manufacturing and delivery, BASF offers solutions for Biopharma, Parenteral, […]
read more
New Member: Welcome in our cluster to Fab’ulous SAS
Fabulous accelerates antibody discovery with a fully computational, AI-powered approach that delivers preclinical ready human antibodies in just 3–5 days. Starting from your scientific problem, it designs candidates using curated human sequence data and in silico maturation to mimic natural immune evolution. This process enhances affinity, thermostability, and expression while reducing off-target binding. Each sequence […]
read more
New Member: Welcome in our cluster to Reactosome Inc
Reactosome Inc is pioneering the Synthetic Nucleus (SN), a next-generation platform for safe, programmable delivery of large genetic cargo and biologics.Inspired by proteinosomes, SNs are stable, cell-sized compartments with tunable release, capable of delivering 14+ kb DNA or producing RNA/proteins in situ. Validated in vivo with no toxicity, SNs offer a virus-free alternative for gene […]
read more
New Member: Welcome in our cluster to QuantiLight GmbH
QuantiLight is a portable blood testing platform for at home monitoring. Millions of patients with chronic diseases require frequent blood monitoring to adapt their medication. Current methods for Therapeutic Drug Monitoring involve taking blood samples in hospitals or laboratories.QuantiLight relieves physicians, laboratories and patients, saving costs and time, and being more convenient for all. If […]
read more
New Member: Welcome in our cluster to GA International Inc.
GA International Inc. is a leading manufacturer of specialty labels, supplying laboratory identification solutions to research laboratories, biobanks, hospitals, and other healthcare institutions. Since its inception, GA International has become a worldwide leader in cryogenic and chemical-resistant labels, strongly dedicated to R&D, product development, and manufacturing. If you would like to learn more, please visit […]
read more
New Member: Welcome in our cluster to Fundess GmbH
Fundess GmbH is a Munich-based consultancy specializing in funding and financing strategies for R&D projects in life sciences and biotech. It supports startups, growth companies, and research institutions in accessing national and European funding, offering strategic planning, proposal development, and execution support with a focus on innovation and impact. If you would like to learn […]
read more
New Member: Welcome in our cluster to Glitther GmbH
GliTTher is a German biotech company committed to transforming glioblastoma treatment. Its mission is to develop precision therapies that eliminate the cells driving tumour relapse and resistance. Leveraging a unique platform to identify and target aggressive glioma-initiating cells through their metabolic vulnerabilities and companion diagnostics, GliTTher aims to deliver durable solutions to patients.The company envisions […]
read more
Europe’s top health start-ups take centre stage: EIT Health Catapult winners are revealed at HLTH Europe
The EIT Health Catapult 9th Edition competition winners were announced on 17 June at HLTH Europe 2025, the conference where global expertise meets local insight to address Europe’s unique healthcare challenges and opportunities. Previous edition winners and finalists have attracted significant interest from leading Life Sciences and HealthTech companies. EIT Health celebrated the next wave of health […]
read more
PEPperPRINT GmbH launches cLIFT technology for next-generation peptide microarrays
Heidelberg, 10th of June 2025 – PEPperPRINT, a global leader in peptide microarray technology, celebrates its 15th anniversary with the launch of its next-generation peptide microarray platform: cLIFT, short for combinatorial Laser-Induced Forward Transfer. The new technology dramatically expands peptide printing capabilities and paves the way for innovative biomedical research applications. Developed in collaboration with Dr. Felix Loeffler of […]
read more
